Effect of plasma exchange on COVID-19 associated excess of von Willebrand factor and inflammation in critically ill patients

Ubiquitous microthromboses in the pulmonary vasculature play a crucial role in the pathogenesis of COVID-19 associated acute respiratory distress syndrome (ARDS). Excess of Willebrand factor (vWf) with intravascular multimer formation was identified as a key driver of this finding. Plasma exchange (...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Seibert, Felix Sebastian (VerfasserIn) , Blázquez Navarro, Arturo (VerfasserIn) , Hölzer, Bodo (VerfasserIn) , Doevelaar, Adrian A. N. (VerfasserIn) , Nußhag, Christian (VerfasserIn) , Merle, Uta (VerfasserIn) , Morath, Christian (VerfasserIn) , Zgoura, Panagiota (VerfasserIn) , Dittmer, Rita (VerfasserIn) , Schneppenheim, Sonja (VerfasserIn) , Wilhelm, Jochen (VerfasserIn) , Babel, Nina (VerfasserIn) , Budde, Ulrich (VerfasserIn) , Westhoff, Timm H. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: Mar 21 2022
In: Scientific reports
Year: 2022, Jahrgang: 12, Pages: 1-8
ISSN:2045-2322
DOI:10.1038/s41598-022-08853-2
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/s41598-022-08853-2
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/s41598-022-08853-2
Volltext
Verfasserangaben:Felix S. Seibert, Arturo Blazquez-Navarro, Bodo Hölzer, Adrian A. N. Doevelaar, Christian Nusshag, Uta Merle, Christian Morath, Panagiota Zgoura, Rita Dittmer, Sonja Schneppenheim, Jochen Wilhelm, Nina Babel, Ulrich Budde & Timm H. Westhoff

MARC

LEADER 00000caa a2200000 c 4500
001 1808421124
003 DE-627
005 20230426090928.0
007 cr uuu---uuuuu
008 220628s2022 xx |||||o 00| ||eng c
024 7 |a 10.1038/s41598-022-08853-2  |2 doi 
035 |a (DE-627)1808421124 
035 |a (DE-599)KXP1808421124 
035 |a (OCoLC)1341461943 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Seibert, Felix Sebastian  |d 1983-  |e VerfasserIn  |0 (DE-588)102002979X  |0 (DE-627)691077649  |0 (DE-576)358654092  |4 aut 
245 1 0 |a Effect of plasma exchange on COVID-19 associated excess of von Willebrand factor and inflammation in critically ill patients  |c Felix S. Seibert, Arturo Blazquez-Navarro, Bodo Hölzer, Adrian A. N. Doevelaar, Christian Nusshag, Uta Merle, Christian Morath, Panagiota Zgoura, Rita Dittmer, Sonja Schneppenheim, Jochen Wilhelm, Nina Babel, Ulrich Budde & Timm H. Westhoff 
264 1 |c Mar 21 2022 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 28.06.2022 
520 |a Ubiquitous microthromboses in the pulmonary vasculature play a crucial role in the pathogenesis of COVID-19 associated acute respiratory distress syndrome (ARDS). Excess of Willebrand factor (vWf) with intravascular multimer formation was identified as a key driver of this finding. Plasma exchange (PLEX) might be a therapeutic option to restore the disbalance between vWf and ADAMTS13. We report the effects of PLEX on vWf, ADAMTS13, inflammatory cytokines and parameters of ventilation. We investigated 25 patients, who were on mechanical ventilation for COVID-19 pneumonia with ARDS at two German university hospitals. All patients received PLEX as an ultima ratio measure for refractory ARDS. VWf antigen (vWf:Ag), ADAMTS13 activity, a cytokine panel mirroring the inflammatory situation and clinical parameters were assessed before and after three to six PLEX therapies with fresh frozen plasma. Before the PLEX sequence there was an excessive release of vWf:Ag (425.4 ± 167.5%) and mildly reduced ADAMTS13 activity (49.7 ± 23.3%). After the PLEX series, there was a significant increase of ADAMTS13 activity to 62.4 ± 17.7% (p = 0.029) and a significant decrease of vWf:Ag to 336.1 ± 138.2% (p = 0.041) resulting in a 63% improvement of the ADAMT13/vWf:Ag ratio from 14.5 ± 10.0 to 23.7 ± 14.6, p = 0.024. Comparison of parameters before and after individual PLEX sessions (n = 35) revealed a mean reduction of vWf from 387.8 ± 165.1 to 213.2 ± 62.3% (p = 0.001) and an increase of ADAMTS13 activity from 60.4 ± 20.1 to 70.5 ± 14.0% (p = 0.001). Parallelly, monocyte chemotactic protein-1 and interleukin-18 decreased significantly (p = 0.034 each). Along the PLEX sequence lactate dehydrogenase (p = 0.001), C-reactive protein (p = 0.001), and positive end expiratory pressure (p = 0.01) significantly decreased accompanied by an improvement of Horovitz index (p = 0.001). PLEX restores the disbalance between ADAMTS13 and vWf:Ag, a driver of immunothrombosis. Moreover, it reduces the inflammatory state and is associated with a benefit of ventilation parameters. These findings render a further rationale to regard PLEX as a therapeutic option in severe COVID-19. 
650 4 |a Nephrology 
650 4 |a Viral infection 
700 1 |a Blázquez Navarro, Arturo  |e VerfasserIn  |0 (DE-588)1209578840  |0 (DE-627)1697239420  |4 aut 
700 1 |a Hölzer, Bodo  |e VerfasserIn  |4 aut 
700 1 |a Doevelaar, Adrian A. N.  |e VerfasserIn  |4 aut 
700 1 |a Nußhag, Christian  |d 1985-  |e VerfasserIn  |0 (DE-588)1054789827  |0 (DE-627)792121376  |0 (DE-576)410521280  |4 aut 
700 1 |a Merle, Uta  |d 1974-  |e VerfasserIn  |0 (DE-588)123211069  |0 (DE-627)706210174  |0 (DE-576)293606854  |4 aut 
700 1 |a Morath, Christian  |d 1973-  |e VerfasserIn  |0 (DE-588)124036155  |0 (DE-627)085595837  |0 (DE-576)293989923  |4 aut 
700 1 |a Zgoura, Panagiota  |e VerfasserIn  |4 aut 
700 1 |a Dittmer, Rita  |e VerfasserIn  |4 aut 
700 1 |a Schneppenheim, Sonja  |e VerfasserIn  |4 aut 
700 1 |a Wilhelm, Jochen  |e VerfasserIn  |4 aut 
700 1 |a Babel, Nina  |e VerfasserIn  |4 aut 
700 1 |a Budde, Ulrich  |e VerfasserIn  |4 aut 
700 1 |a Westhoff, Timm H.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Scientific reports  |d [London] : Springer Nature, 2011  |g 12(2022), Artikel-ID 4801, Seite 1-8  |h Online-Ressource  |w (DE-627)663366712  |w (DE-600)2615211-3  |w (DE-576)346641179  |x 2045-2322  |7 nnas  |a Effect of plasma exchange on COVID-19 associated excess of von Willebrand factor and inflammation in critically ill patients 
773 1 8 |g volume:12  |g year:2022  |g elocationid:4801  |g pages:1-8  |g extent:8  |a Effect of plasma exchange on COVID-19 associated excess of von Willebrand factor and inflammation in critically ill patients 
856 4 0 |u https://doi.org/10.1038/s41598-022-08853-2  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/s41598-022-08853-2  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220628 
993 |a Article 
994 |a 2022 
998 |g 124036155  |a Morath, Christian  |m 124036155:Morath, Christian  |p 8 
998 |g 123211069  |a Merle, Uta  |m 123211069:Merle, Uta  |p 7 
999 |a KXP-PPN1808421124  |e 4157587898 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1808421124","note":["Gesehen am 28.06.2022"],"language":["eng"],"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"Mar 21 2022"}],"name":{"displayForm":["Felix S. Seibert, Arturo Blazquez-Navarro, Bodo Hölzer, Adrian A. N. Doevelaar, Christian Nusshag, Uta Merle, Christian Morath, Panagiota Zgoura, Rita Dittmer, Sonja Schneppenheim, Jochen Wilhelm, Nina Babel, Ulrich Budde & Timm H. Westhoff"]},"person":[{"role":"aut","given":"Felix Sebastian","family":"Seibert","display":"Seibert, Felix Sebastian"},{"family":"Blázquez Navarro","display":"Blázquez Navarro, Arturo","role":"aut","given":"Arturo"},{"given":"Bodo","role":"aut","display":"Hölzer, Bodo","family":"Hölzer"},{"display":"Doevelaar, Adrian A. N.","family":"Doevelaar","given":"Adrian A. N.","role":"aut"},{"family":"Nußhag","display":"Nußhag, Christian","role":"aut","given":"Christian"},{"family":"Merle","display":"Merle, Uta","role":"aut","given":"Uta"},{"role":"aut","given":"Christian","family":"Morath","display":"Morath, Christian"},{"given":"Panagiota","role":"aut","display":"Zgoura, Panagiota","family":"Zgoura"},{"given":"Rita","role":"aut","display":"Dittmer, Rita","family":"Dittmer"},{"display":"Schneppenheim, Sonja","family":"Schneppenheim","given":"Sonja","role":"aut"},{"family":"Wilhelm","display":"Wilhelm, Jochen","role":"aut","given":"Jochen"},{"display":"Babel, Nina","family":"Babel","given":"Nina","role":"aut"},{"display":"Budde, Ulrich","family":"Budde","given":"Ulrich","role":"aut"},{"given":"Timm H.","role":"aut","display":"Westhoff, Timm H.","family":"Westhoff"}],"id":{"eki":["1808421124"],"doi":["10.1038/s41598-022-08853-2"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"id":{"eki":["663366712"],"issn":["2045-2322"],"zdb":["2615211-3"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Scientific reports","title_sort":"Scientific reports"}],"pubHistory":["1, article number 1 (2011)-"],"disp":"Effect of plasma exchange on COVID-19 associated excess of von Willebrand factor and inflammation in critically ill patientsScientific reports","recId":"663366712","part":{"extent":"8","pages":"1-8","volume":"12","text":"12(2022), Artikel-ID 4801, Seite 1-8","year":"2022"},"note":["Gesehen am 12.07.24"],"language":["eng"],"origin":[{"publisherPlace":"[London] ; London","dateIssuedKey":"2011","dateIssuedDisp":"2011-","publisher":"Springer Nature ; Nature Publishing Group"}]}],"title":[{"title":"Effect of plasma exchange on COVID-19 associated excess of von Willebrand factor and inflammation in critically ill patients","title_sort":"Effect of plasma exchange on COVID-19 associated excess of von Willebrand factor and inflammation in critically ill patients"}],"physDesc":[{"extent":"8 S."}]} 
SRT |a SEIBERTFELEFFECTOFPL2120